Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer

被引：1
|
作者：
van der Poel, Henk [1 ]
机构：
[1] Netherlands Canc Inst, Dept Urol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands
来源：
EUROPEAN UROLOGY OPEN SCIENCE | 2021年 / 34卷
关键词：
EFFICACY;
D O I：
10.1016/j.euros.2021.08.011
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：68 / 69
页数：2
相关论文
共 50 条
  • [21] Utility of Ga68 prostate-specific membrane antigen positron-emission tomography for pre-operative staging of high-risk prostate cancer in a prospective cohort
    Tarr, Gregory Patrick
    Kashyap, Puja
    Dixit, Devesh Datta
    Willams, Andrew Keith
    Koya, Madhusudhan Prasad
    Lim, Remy
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2020, 64 (01) : 78 - 86
  • [22] The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer
    Koschel, Samantha
    Murphy, Declan G.
    Hofman, Michael S.
    Wong, Lih-Ming
    CURRENT OPINION IN UROLOGY, 2019, 29 (06) : 569 - 577
  • [23] Positron Emission Tomography-computed Tomography with Prostate-specific Membrane Antigen Ligands as a Promising Tool for Imaging of Prostate Cancer
    Haberkorn, Uwe
    Kopka, Klaus
    Hadaschik, Boris
    EUROPEAN UROLOGY, 2016, 69 (03) : 397 - 399
  • [24] Re: Performance of a Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-derived Risk-stratification Tool for High-risk and Very High-risk Prostate Cancer
    Bjartell, Anders
    EUROPEAN UROLOGY, 2022, 82 (01) : 145 - 146
  • [25] Predicting early outcomes in patients with intermediate- and high-risk prostate cancer using prostate-specific membrane antigen positron emission tomography and magnetic resonance imaging
    Meijer, Dennie
    van Leeuwen, Pim J.
    Donswijk, Maarten L.
    Boellaard, Thierry N.
    Schoots, Ivo G.
    van der Poel, Henk G.
    Hendrikse, Harry N.
    Oprea-Lager, Daniela E.
    Vis, Andre N.
    BJU INTERNATIONAL, 2022, 129 (01) : 54 - 62
  • [26] How prostate-specific membrane antigen positron emission tomography is refining risk calculators in the primary prostate diagnostic pathway
    Ptasznik, Gideon
    Kelly, Brian D.
    Murphy, Declan
    Lawrentschuk, Nathan
    Kasivisvanathan, Veeru
    Page, Mark
    Ong, Sean
    Moon, Daniel
    BJU INTERNATIONAL, 2023,
  • [27] Prostate-specific Membrane Antigen Positron Emission Tomography in the Staging of Newly Diagnosed Prostate Cancer: Is More Sensitivity Always Better?
    Varatharajan, Abirramy
    Olivier, Timothee
    Prasad, Vinay
    EUROPEAN UROLOGY, 2023, 83 (06) : 481 - 483
  • [28] Impact of a Novel Molecular Imaging Modality, Prostate-Specific Membrane Antigen Positron Emission Tomography, on the Management of Prostate Cancer
    Patel, Neal A.
    Reiter, Robert E.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (13) : 1497 - +
  • [29] Prostate-specific membrane antigen PET/computed tomography for staging prostate cancer
    Ravi Kumar, Aravind S.
    Lawrentschuk, Nathan
    Hofman, Michael S.
    CURRENT OPINION IN UROLOGY, 2020, 30 (05) : 628 - 634
  • [30] In primary lymph nodal staging of patients with high-risk and intermediate-risk prostate cancer, how critical is the role of Gallium-68 prostate-specific membrane antigen positron emission tomography-computed tomography?
    Kulkarni, Smita Chinmay
    Sundaram, Palaniswamy Shanmuga
    Padma, Subramanyam
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (02) : 139 - 146
12345